Advertisement
UK markets close in 3 hours 40 minutes
  • FTSE 100

    8,089.29
    +44.48 (+0.55%)
     
  • FTSE 250

    19,806.02
    +6.30 (+0.03%)
     
  • AIM

    754.89
    +0.02 (+0.00%)
     
  • GBP/EUR

    1.1636
    +0.0008 (+0.07%)
     
  • GBP/USD

    1.2433
    -0.0019 (-0.16%)
     
  • Bitcoin GBP

    53,460.97
    +408.66 (+0.77%)
     
  • CMC Crypto 200

    1,438.51
    +14.41 (+1.01%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CRUDE OIL

    82.85
    -0.51 (-0.61%)
     
  • GOLD FUTURES

    2,328.80
    -13.30 (-0.57%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • DAX

    18,198.11
    +60.46 (+0.33%)
     
  • CAC 40

    8,140.30
    +34.52 (+0.43%)
     

Why Shares of BioNTech Rose Friday

Why Shares of BioNTech Rose Friday

Shares of BioNTech (NASDAQ: BNTX) were up as by much as 5.3% on Friday before closing the session up 3.85% after the biotech company announced positive news regarding a clinical trial for its non-small cell lung cancer therapy candidate. The company focuses on immunotherapies to treat cancer, infectious diseases, and other diseases. BioNTech's shares have been sliding because sales of Comirnaty, the COVID-19 vaccine it developed with Pfizer, are falling.